AMED:XETRA:XETRA-Amundi Index Solutions - Amundi ETF MSCI EMU ESG Leaders Select (EUR)

ETF | Others |

Last Closing

USD 286.1

Change

0.00 (0.00)%

Market Cap

USD 1.22B

Volume

147.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+1.44 (+3.51%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

+2.41 (+2.75%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.76 (+3.64%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.46 (+3.89%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.17 (+3.51%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.72 (+3.50%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.31 (+2.76%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.63 (-1.14%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.31 (+3.36%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.30 (+0.25%)

USD 12.26B

ETFs Containing AMED:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.27% 70% C- 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.27% 72% C 68% D+
Trailing 12 Months  
Capital Gain -1.36% 60% D- 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.36% 62% D 60% D-
Trailing 5 Years  
Capital Gain 65.70% 72% C 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 65.70% 73% C 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 10.87% 67% D+ 66% D+
Dividend Return 10.87% 66% D+ 65% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.95% 41% F 52% F
Risk Adjusted Return 77.90% 67% D+ 71% C-
Market Capitalization 1.22B 85% B 65% D

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.